Report copyright - TITLE PAGE (30pt Arial Narrow)...Target Agent N 1o End Point Result VEGF Docetaxel ± bevacizumab (NCT00110214) 1,050 OS OS not improved HR, 0.91; 95% CI, 0.78 to 1.05 VEGF Docetaxel
Please pass captcha verification before submit form